GDF15 shows an anti-cardiac hypertrophy effect via the Smad2/3 pathway [37], whereas in cardiomyocytes cultured with GDF15, it exerted a pro-hypertrophic effect via the Smad1 pathway [38]. This evidence concerns the gene GDF15 and cardiac hypertrophy.